Back to AVBP

D. E. Shaw & Co., Inc. → AVBP

D. E. Shaw & Co., Inc. AVBP Position History

ArriVent BioPharma, Inc. • Healthcare

Quarters held
6
Latest value
$787K
Q3 2026
Peak value
$30.3M
First seen
Q3 2024

Dollar value over time

Show data table
PeriodPosition value
Q3 2024$206K
Q4 2025$4.7M
Q1 2026$8.5M
Q2 2026$30.3M
Q3 2026$26.7M
Q3 2026$787K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$787K26.0K——
Q3 2026$26.7M882.5K——
Q2 2026$30.3M872.0K——
Q1 2026$8.5M368.8K——
Q4 2025$4.7M233.3K——
Q3 2024$206K8.8K——

Other funds holding AVBP

Other D. E. Shaw & Co., Inc. positions

SPY

STATE STR SPDR S&P 500 ETF T

$7.6B
SPY

STATE STR SPDR S&P 500 ETF T

$6.8B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
SPY

SPDR S&P 500 ETF TR

$2B
NVDA

NVIDIA CORPORATION

$2B